Skip to main content

HCA Healthcare, Inc. ownership: holders and insider trading

  • HCA · NYSE
  • Healthcare
  • Health Care Facilities
  • S&P 500
$499.05−0.32%Close 13 Nov 2026 · Market value $107.0B

As filed, its directors and officers own 1.5% of the shares (proxy statement, 23 Feb 2026); 1,331 institutional managers reported holding 63.8% at 30 Jun 2026. Over the last twelve months, insiders sold $29.87M of shares on the open market, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
Thomas F. Frist IIIInsider · active70.5M33.8%Schedule 13D6 Nov 2026
Frisco Holding IIHolder38.9M17.4%Proxy statement23 Feb 2026
Hercules Holding IIHolder34.6M15.5%Proxy statement23 Feb 2026
The Vanguard GroupHolder14.5M6.87%*Form 13F30 Jun 2026
BlackRockInstitution13.0M6.17%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder11.7M5.25%Schedule 13G31 Mar 2026
Sanders Capital, LLCInstitution8.8M4.19%*Form 13F30 Jun 2026
State StreetInstitution7.5M3.54%*Form 13F30 Jun 2026
First Eagle Investment Management, LLCInstitution6.6M3.13%*Form 13F30 Jun 2026
Wellington ManagementInstitution4.7M2.23%*Form 13F30 Jun 2026
Capital GroupInstitution3.9M1.85%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution3.7M1.74%*Form 13F30 Jun 2026
Morgan StanleyInstitution2.6M1.23%*Form 13F30 Jun 2026
Goldman SachsInstitution2.5M1.17%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution2.3M1.08%*Form 13F30 Jun 2026
Arrowstreet Capital, Limited PartnershipInstitution2.2M1.05%*Form 13F30 Jun 2026
Samuel N. HazenInsider2.2M< 1%Proxy statement23 Feb 2026
Norges BankInstitution2.1M1.02%*Form 13F30 Jun 2026
UBSInstitution1.8M0.87%*Form 13F30 Jun 2026
Northern TrustInstitution1.7M0.81%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Schlosser Michael J · EVP and Chief Clinical Officer4 Nov 2026Open-market sale−1.2K$494.65$593.6K
Marks Mike A · EVP and CFO30 Oct 2026Option exercise+4.6K$81.96$375.8K
Marks Mike A · EVP and CFO30 Oct 2026Shares withheld for tax−2.3K$473.19$1.08M
Schlosser Michael J · EVP and Chief Clinical Officer29 Oct 2026Option exercise+3.0K$81.96$248.3K
Schlosser Michael J · EVP and Chief Clinical Officer29 Oct 2026Option exercise+1.9K$82.85$157.2K
Schlosser Michael J · EVP and Chief Clinical Officer29 Oct 2026Shares withheld for tax−2.5K$478.08$1.17M
Smith Andrea B · Director28 Apr 2026Grant or award+509——
Riley Wayne Joseph · Director28 Apr 2026Grant or award+509——
MICHELSON MICHAEL W · Director28 Apr 2026Grant or award+925——
Johnston Hugh F · Director28 Apr 2026Grant or award+809——
DEPARLE NANCY ANN · Director28 Apr 2026Grant or award+509——
CHIDSEY JOHN · Director28 Apr 2026Grant or award+809——
Frist William R · Director · 10% owner28 Apr 2026Grant or award+809——
FRIST THOMAS F III · Director · 10% owner28 Apr 2026Grant or award+1.0K——
McAlevey Michael R · EVP & Chief Legal & Admin Off.18 Feb 2026Open-market sale−1.7K$533.37$903.5K
McAlevey Michael R · EVP & Chief Legal & Admin Off.13 Feb 2026Shares withheld for tax−3.3K$540.29$1.79M
McAlevey Michael R · EVP & Chief Legal & Admin Off.13 Feb 2026Option exercise+5.0K$236.61$1.18M
Wyatt Christopher F. · SVP & Controller11 Feb 2026Open-market sale−4.0K$505.00$2.02M
Berres Jennifer · SVP & Chief Human Res. Officer11 Feb 2026Open-market sale−4.0K$526.16$2.11M
Berres Jennifer · SVP & Chief Human Res. Officer11 Feb 2026Open-market sale−4.0K$503.00$2.02M
Wyatt Christopher F. · SVP & Controller10 Feb 2026Grant or award+3.4K——
Wyatt Christopher F. · SVP & Controller10 Feb 2026Shares withheld for tax−1.0K$502.05$519.1K
Rossitto Erica · SVP & Chief Nurse Executive10 Feb 2026Shares withheld for tax−418$502.05$209.9K
Rossitto Erica · SVP & Chief Nurse Executive10 Feb 2026Grant or award+1.7K——
McAlevey Michael R · EVP & Chief Legal & Admin Off.10 Feb 2026Grant or award+8.4K——

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

HCA in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.